Answers are grounded in this paper and cite their sources.
Piceatannol is a plant-derived stilbenoid compound, exhibiting physiological activities such as antioxidant, anti-inflammatory, and anti-tumor effects, which endow it with significant application value in the food, pharmaceutical, and cosmetic industries. In recent years, the biosynthesis of piceatannol via microbial cell factories has attracted widespread attention, as it provides a safe and efficient route for the production of this compound. This review begins by introducing the biosynthetic pathway and relevant enzymes of piceatannol, followed by an in-depth analysis of the characteristics of microbial hosts used for its production. Subsequently, the main strategies for piceatannol production in microbial hosts, including the construction of efficient heterologous biosynthetic pathways, directed engineering of rate-limiting enzymes, supply of cofactors, enhancement of precursor metabolic flux, and optimization of the production process, are systematically summarized and discussed. Finally, the future prospects and perspectives for the microbial production of piceatannol are discussed.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: